Hearing: Cannabis Policies for the New Decade

Subcommittee on Health (Committee on Energy and Commerce)

Wednesday, January 15, 2020 (10:00 AM - 12:00 PM)

2123 RHOB
Washington, D.C.

Witnesses

Mr. Matthew J. Strait
Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration

Added 01/13/2020 at 04:20 PM
  • Witness Statement [PDF] Added 01/13/2020 at 06:05 PM

Dr. Douglas Throckmorton
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration

Added 01/13/2020 at 04:20 PM
  • Witness Statement [PDF] Added 01/14/2020 at 11:38 AM

Dr. Nora D. Volkow
Director, National Institute on Drug Abuse, National Institutes of Health

Added 01/13/2020 at 04:20 PM
  • Witness Statement [PDF] Added 01/14/2020 at 11:38 AM

Text of Legislation

  • H.R. 171, the “Legitimate Use of Medicinal Marijuana Act” [PDF] Added 01/13/2020 at 04:20 PM
  • H.R. 601, the “Medical Cannabis Research Act of 2019” [PDF] Added 01/13/2020 at 04:20 PM
  • H.R. 1151, the “Veterans Medical Marijuana Safe Harbor Act” [PDF] Added 01/13/2020 at 04:20 PM
  • H.R. 2843, the "Marijuana Freedom and Opportunity Act" [PDF] Added 01/13/2020 at 04:20 PM
  • H.R. 3797, the “Medical Marijuana Research Act of 2019” [PDF] Added 01/13/2020 at 04:20 PM
  • H.R. 3884, the “Marijuana Opportunity Reinvestment and Expungement Act of 2019” or the “MORE Act of 2019” [PDF] Added 01/13/2020 at 04:20 PM

Support Documents

  • Notice of Hearing [PDF]
  • Briefing Memo [PDF] Added 01/13/2020 at 04:20 PM

First Published: January 8, 2020 at 09:46 PM
Last Updated: January 24, 2020 at 03:08 PM